Please login to the form below

Not currently logged in
Email:
Password:

Just::

This page shows the latest Just:: news and features for those working in and with pharma, biotech and healthcare.

Sanofi sells European generics to Advent for $2.4bn

Sanofi sells European generics to Advent for $2.4bn

Just this month, for example, GlaxoSmithKline divested its rare disease portfolio to start-up Orchard Therapeutics, after buying Novartis out of a consumer health joint venture in March, and Shire has

Latest news

More from news
Approximately 6 fully matching, plus 1,025 partially matching documents found.

Latest Intelligence

  • Brexit Means Brexit Brexit Means Brexit

    That is why the Prime Minister’s commitment to seek cooperation on medicines regulation would be the best outcome for patients, not just in the UK but across Europe.”However, close ... As we know, any changes in regulation that affect the movement of

  • Beyond caring: learning from the unsung advocates in cancer care

    UK. Broadly, carers in and outside cancer contribute around £132 billion in unpaid care every year - only just shy of the £134 billion that is spent in UK public health spending. ... Advocates are passionate about helping their loved ones and doing

  • The challenges of making genomics a reality for patients The challenges of making genomics a reality for patients

    a mutation in a single gene. It is hard to imagine that in many cases changing just three letters in a three billion genetic code could have such profound consequences.

  • A new era of smart pharma A new era of smart pharma

    The McKinsey Global Institute expects that, within five to seven years, a significant proportion of the pharmaceutical portfolio will create value through more than just drugs. ... Virtual doctors are just one element of the multiple channels that will

  • Is trust in healthcare improving? Is trust in healthcare improving?

    On a scale of 0-100, the public placed an importance of 84 on transparency and authenticity, while the industry’s performance ranks at just 61.

More from intelligence
Approximately 1 fully matching, plus 418 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 60 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 398 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics